Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 176
Filter
Add more filters

Publication year range
1.
Biochem Biophys Res Commun ; 733: 150575, 2024 Nov 12.
Article in English | MEDLINE | ID: mdl-39197199

ABSTRACT

Flavin monooxygenases (FMOs) have been widely used in the biosynthesis of natural compounds due to their excellent stereoselectivity, regioselectivity and chemoselectivity. Stenotrophomonas maltophilia flavin monooxygenase (SmFMO) has been reported to catalyze the oxidation of various thiols to corresponding sulfoxides, but its activity is relatively low. Herein, we obtained a mutant SmFMOF52G which showed 4.35-fold increase in kcat/Km (4.96 mM-1s-1) and 6.84-fold increase in enzyme activity (81.76 U/g) compared to the SmFMOWT (1.14 mM-1s-1 and 11.95 U/g) through semi-rational design guided by structural analysis and catalytic mechanism combined with high-throughput screening. By forming hydrogen bond with O4 atom of FAD isoalloxazine ring and reducing steric hindrance, the conformation of FAD isoalloxazine ring in SmFMOF52G is more stable, and NADPH and substrate are closer to FAD isoalloxazine ring, shortening the distances of hydrogen transfer and substrate oxygenation, thereby increasing the rate of reduction and oxidation reactions and enhancing enzyme activity. Additionally, the overall structural stability and substrate binding capacity of the SmFMOF52G have significant improved than that of SmFMOWT. The strategy used in this study to improve the enzyme activity of FMOs may have generality, providing important references for the rational and semi-rational engineering of FMOs.


Subject(s)
Flavin-Adenine Dinucleotide , Flavins , Oxygenases , Flavin-Adenine Dinucleotide/metabolism , Flavin-Adenine Dinucleotide/chemistry , Flavins/metabolism , Flavins/chemistry , Oxygenases/metabolism , Oxygenases/chemistry , Oxygenases/genetics , Stenotrophomonas maltophilia/enzymology , Bacterial Proteins/metabolism , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Models, Molecular , Oxidation-Reduction , Substrate Specificity , Kinetics
2.
J Chem Inf Model ; 64(9): 3706-3717, 2024 May 13.
Article in English | MEDLINE | ID: mdl-38687957

ABSTRACT

L2 ß-lactamases, serine-based class A ß-lactamases expressed by Stenotrophomonas maltophilia, play a pivotal role in antimicrobial resistance (AMR). However, limited studies have been conducted on these important enzymes. To understand the coevolutionary dynamics of L2 ß-lactamase, innovative computational methodologies, including adaptive sampling molecular dynamics simulations, and deep learning methods (convolutional variational autoencoders and BindSiteS-CNN) explored conformational changes and correlations within the L2 ß-lactamase family together with other representative class A enzymes including SME-1 and KPC-2. This work also investigated the potential role of hydrophobic nodes and binding site residues in facilitating the functional mechanisms. The convergence of analytical approaches utilized in this effort yielded comprehensive insights into the dynamic behavior of the ß-lactamases, specifically from an evolutionary standpoint. In addition, this analysis presents a promising approach for understanding how the class A ß-lactamases evolve in response to environmental pressure and establishes a theoretical foundation for forthcoming endeavors in drug development aimed at combating AMR.


Subject(s)
Deep Learning , Molecular Dynamics Simulation , beta-Lactamases , beta-Lactamases/metabolism , beta-Lactamases/chemistry , Evolution, Molecular , Protein Conformation , Stenotrophomonas maltophilia/enzymology
3.
J Biol Chem ; 297(4): 101014, 2021 10.
Article in English | MEDLINE | ID: mdl-34358563

ABSTRACT

Polysaccharide lyases (PLs) are a broad class of microbial enzymes that degrade anionic polysaccharides. Equally broad diversity in their polysaccharide substrates has attracted interest in biotechnological applications such as biomass conversion to value-added chemicals and microbial biofilm removal. Unlike other PLs, Smlt1473 present in the clinically relevant Stenotrophomonas maltophilia strain K279a demonstrates a wide range of pH-dependent substrate specificities toward multiple, diverse polysaccharides: hyaluronic acid (pH 5.0), poly-ß-D-glucuronic (celluronic) acid (pH 7.0), poly-ß-D-mannuronic acid, and poly-α-L-guluronate (pH 9.0). To decode the pH-driven multiple substrate specificities and selectivity in this single enzyme, we present the X-ray structures of Smlt1473 determined at multiple pH values in apo and mannuronate-bound states as well as the tetra-hyaluronate-docked structure. Our results indicate that structural flexibility in the binding site and N-terminal loop coupled with specific substrate stereochemistry facilitates distinct modes of entry for substrates having diverse charge densities and chemical structures. Our structural analyses of wild-type apo structures solved at different pH values (5.0-9.0) and pH-trapped (5.0 and 7.0) catalytically relevant wild-type mannuronate complexes (1) indicate that pH modulates the catalytic microenvironment for guiding structurally and chemically diverse polysaccharide substrates, (2) further establish that molecular-level fluctuation in the enzyme catalytic tunnel is preconfigured, and (3) suggest that pH modulates fluctuations resulting in optimal substrate binding and cleavage. Furthermore, our results provide key insight into how strategies to reengineer both flexible loop and regions distal to the active site could be developed to target new and diverse substrates in a wide range of applications.


Subject(s)
Bacterial Proteins/chemistry , Polysaccharide-Lyases/chemistry , Stenotrophomonas maltophilia/enzymology , Hydrogen-Ion Concentration , Protein Domains , Structure-Activity Relationship , Substrate Specificity
4.
Bioorg Med Chem Lett ; 36: 127787, 2021 03 15.
Article in English | MEDLINE | ID: mdl-33460740

ABSTRACT

SmltD is an ATP-dependent ligase that catalyzes the condensation of UDP-MurNAc-l-Ala and l-Glu to form UDP-MurNAc-l-Ala-l-Glu, in the newly discovered peptidoglycan biosynthesis pathway of a Gram-negative multiple-drug-resistant pathogen, Stenotrophomonas maltophilia. Phytochemical investigation of the 70% ethanol extract from Woodfordia fruticosa flowers collected in Myanmar led to the identification of anti-SmltD active flavonoids, kaempferol 3-O-(6''-galloyl)-ß-d-glucopyranoside (1), astragalin (2), and juglalin (3). Among them, 1 showed the most potent SmltD inhibitory activity. An enzyme steady-state kinetic study revealed that 1 exerted competitive inhibition with respect to ATP. The results of this study provided an attractive foundation for the further development of novel inhibitors of SmltD.


Subject(s)
DNA Ligase ATP/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Flavonoids/pharmacology , Peptidoglycan/biosynthesis , Woodfordia/chemistry , DNA Ligase ATP/metabolism , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/isolation & purification , Flavonoids/chemistry , Flavonoids/isolation & purification , Molecular Structure , Peptidoglycan/chemistry , Stenotrophomonas maltophilia/enzymology , Structure-Activity Relationship
5.
Int J Mol Sci ; 22(17)2021 Aug 29.
Article in English | MEDLINE | ID: mdl-34502284

ABSTRACT

Metallo-ß-lactamases (MBLs) are class B ß-lactamases from the metallo-hydrolase-like MBL-fold superfamily which act on a broad range of ß-lactam antibiotics. A previous study on BLEG-1 (formerly called Bleg1_2437), a hypothetical protein from Bacillus lehensis G1, revealed sequence similarity and activity to B3 subclass MBLs, despite its evolutionary divergence from these enzymes. Its relatedness to glyoxalase II (GLXII) raises the possibility of its enzymatic promiscuity and unique structural features compared to other MBLs and GLXIIs. This present study highlights that BLEG-1 possessed both MBL and GLXII activities with similar catalytic efficiencies. Its crystal structure revealed highly similar active site configuration to YcbL and GloB GLXIIs from Salmonella enterica, and L1 B3 MBL from Stenotrophomonas maltophilia. However, different from GLXIIs, BLEG-1 has an insertion of an active-site loop, forming a binding cavity similar to B3 MBL at the N-terminal region. We propose that BLEG-1 could possibly have evolved from GLXII and adopted MBL activity through this insertion.


Subject(s)
Bacillus/enzymology , Bacterial Proteins/chemistry , Bacterial Proteins/metabolism , Thiolester Hydrolases/chemistry , beta-Lactamases/chemistry , Ampicillin/chemistry , Ampicillin/metabolism , Bacterial Proteins/genetics , Binding Sites , Catalytic Domain , Crystallography, X-Ray , Evolution, Molecular , Glutathione/analogs & derivatives , Glutathione/chemistry , Glutathione/metabolism , Molecular Docking Simulation , Phylogeny , Protein Conformation , Stenotrophomonas maltophilia/enzymology
6.
J Wound Care ; 29(Sup12): S38-S43, 2020 Dec 01.
Article in English | MEDLINE | ID: mdl-33320761

ABSTRACT

OBJECTIVE: The purpose of this study was to identify the potential of resveratrol in inhibiting the growth and production of two enzymes, hyaluronidase and protease, in Stenotrophomonas maltophilia, which has become a burn wound pathogen of great significance. METHOD: Stenotrophomonas maltophilia (ATCC 17666) was cultured in nutrient broth and the microbial load was standardised to 0.5 McFarland standard at 600nm. The study included antimicrobial assays (well diffusion and resazurin dye binding method), hyaluronidase expression regulation assay (hyaluronic acid hydrolysis assay and turbidity assay) and protease expression regulation assay (casein hydrolysis assay and determination of specific activity of protease using tyrosine standard). RESULTS: The minimum inhibitory concentration (MIC) of resveratrol against Stenotrophomonas maltophilia was found to be 125µg/ml. Hyaluronidase production in the organism treated with resveratrol was found to be half that in the untreated organism. The specific activity of protease produced by the organism treated with resveratrol was found to be one-quarter that in the untreated organism, as analysed by the tyrosine standard estimation protocol. CONCLUSION: Resveratrol was found to be a potent compound to treat Stenotrophomonas maltophilia infections. In addition to the antimicrobial and enzyme-regulatory properties of resveratrol, it also shows anti-oxidant and anti-inflammatory properties. This finding has great scope clinically as resveratrol may prove to be an ideal drug to treat burn wound infections.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Burns/drug therapy , Resveratrol/pharmacology , Stenotrophomonas maltophilia/drug effects , Burns/pathology , Gram-Negative Bacterial Infections/drug therapy , Humans , Microbial Sensitivity Tests , Resveratrol/therapeutic use , Stenotrophomonas maltophilia/enzymology
7.
Article in English | MEDLINE | ID: mdl-31427295

ABSTRACT

We evaluated the activity of minocycline and comparator agents against a large number of Stenotrophomonas maltophilia (n = 1,289), Acinetobacter baumannii-Acinetobacter calcoaceticus species complex (n = 1,081), and Burkholderia cepacia complex (n = 101) isolates collected from 2014 to 2018 from 87 U.S. medical centers spanning all 9 census divisions. The isolates were collected primarily from hospitalized patients with pneumonia (1,632 isolates; 66.0% overall), skin and skin structure infections (354 isolates; 14.3% overall), bloodstream infections (266 isolates; 10.8% overall), urinary tract infections (126 isolates; 5.1% overall), intra-abdominal infections (61 isolates; 2.5% overall), and other infections (32 isolates; 1.3% overall). Against the A. baumannii-A. calcoaceticus species complex, colistin was the most active agent, exhibiting MIC50/90 values at ≤0.5/2 µg/ml and 92.4% susceptibility. Minocycline ranked second in activity, with MIC50/90 values at 0.25/8 µg/ml and susceptibility at 85.7%. Activity for these two agents was reduced against extensively drug-resistant and multidrug-resistant isolates of the Acinetobacter baumannii-Acinetobacter calcoaceticus species complex. Only two agents showed high levels of activity (susceptibility, >90%) against S. maltophilia, minocycline (MIC50/90, 0.5/2 µg/ml; 99.5% susceptible) and trimethoprim-sulfamethoxazole (MIC50/90, ≤0.5/1 µg/ml; 94.6% susceptible). Minocycline was active against 92.8% (MIC90, 4 µg/ml) of trimethoprim-sulfamethoxazole-resistant S. maltophilia isolates. Various agents exhibited susceptibility rates of nearly 90% against the B. cepacia complex isolates; these were trimethoprim-sulfamethoxazole (MIC50/90, ≤0.5/2 µg/ml; 93.1% susceptible), ceftazidime (MIC50/90, 2/8 µg/ml; 91.0% susceptible), meropenem (MIC50/90, 2/8 µg/ml; 89.1% susceptible), and minocycline (MIC50/90, 2/8 µg/ml; 88.1% susceptible). These results indicate that minocycline is among the most active agents for these three problematic potential pathogen groups when tested against U.S. isolates.


Subject(s)
Acinetobacter baumannii/drug effects , Acinetobacter calcoaceticus/drug effects , Burkholderia cepacia complex/drug effects , Minocycline/pharmacology , Stenotrophomonas maltophilia/enzymology , Acinetobacter Infections/drug therapy , Anti-Bacterial Agents/pharmacology , Burkholderia Infections/drug therapy , Ceftazidime/pharmacology , Colistin/pharmacology , Drug Resistance, Multiple, Bacterial/drug effects , Gram-Negative Bacterial Infections/drug therapy , Humans , Microbial Sensitivity Tests/methods , Trimethoprim, Sulfamethoxazole Drug Combination/pharmacology
8.
Article in English | MEDLINE | ID: mdl-30323050

ABSTRACT

The activity of the siderophore cephalosporin cefiderocol is targeted against carbapenem-resistant Gram-negative bacteria. In this study, the activity of cefiderocol against characterized carbapenem-resistant Acinetobacter baumannii complex, Stenotrophomonas maltophilia, Pseudomonas aeruginosa, and Enterobacteriaceae strains was determined by microdilution in iron-depleted Mueller-Hinton broth. The MIC90s against A. baumannii, S. maltophilia, and P. aeruginosa were 1, 0.25, and 0.5 mg/liter, respectively. Against Enterobacteriaceae, the MIC90 was 1 mg/liter for the group harboring OXA-48-like, 2 mg/liter for the group harboring KPC-3, and 8 mg/liter for the group harboring TEM/SHV ESBL, NDM, and KPC-2.


Subject(s)
Acinetobacter baumannii/drug effects , Anti-Bacterial Agents/pharmacology , Cephalosporins/pharmacology , Enterobacteriaceae/drug effects , Pseudomonas aeruginosa/drug effects , Stenotrophomonas maltophilia/drug effects , beta-Lactamases/genetics , Acinetobacter baumannii/enzymology , Acinetobacter baumannii/genetics , Acinetobacter baumannii/growth & development , Culture Media , Enterobacteriaceae/enzymology , Enterobacteriaceae/genetics , Enterobacteriaceae/growth & development , Gene Expression , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/microbiology , Humans , Microbial Sensitivity Tests , Pseudomonas aeruginosa/enzymology , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/growth & development , Siderophores/pharmacology , Stenotrophomonas maltophilia/enzymology , Stenotrophomonas maltophilia/genetics , Stenotrophomonas maltophilia/growth & development , beta-Lactam Resistance/drug effects , beta-Lactam Resistance/genetics , beta-Lactamases/metabolism , Cefiderocol
9.
Article in English | MEDLINE | ID: mdl-31383664

ABSTRACT

ß-Lactamase production is the major ß-lactam resistance mechanism in Gram-negative bacteria. ß-Lactamase inhibitors (BLIs) efficacious against serine ß-lactamase (SBL) producers, especially strains carrying the widely disseminated class A enzymes, are required. Relebactam, a diazabicyclooctane (DBO) BLI, is in phase 3 clinical trials in combination with imipenem for the treatment of infections by multidrug-resistant Enterobacteriaceae We show that relebactam inhibits five clinically important class A SBLs (despite their differing spectra of activity), representing both chromosomal and plasmid-borne enzymes, i.e., the extended-spectrum ß-lactamases L2 (inhibition constant 3 µM) and CTX-M-15 (21 µM) and the carbapenemases KPC-2, -3, and -4 (1 to 5 µM). Against purified class A SBLs, relebactam is an inferior inhibitor compared with the clinically approved DBO avibactam (9- to 120-fold differences in half maximal inhibitory concentration [IC50]). MIC assays indicate relebactam potentiates ß-lactam (imipenem) activity against KPC-producing Klebsiella pneumoniae, with similar potency to avibactam (with ceftazidime). Relebactam is less effective than avibactam in combination with aztreonam against Stenotrophomonas maltophilia K279a. X-ray crystal structures of relebactam bound to CTX-M-15, L2, KPC-2, KPC-3, and KPC-4 reveal its C2-linked piperidine ring can sterically clash with Asn104 (CTX-M-15) or His/Trp105 (L2 and KPCs), rationalizing its poorer inhibition activity than that of avibactam, which has a smaller C2 carboxyamide group. Mass spectrometry and crystallographic data show slow, pH-dependent relebactam desulfation by KPC-2, -3, and -4. This comprehensive comparison of relebactam binding across five clinically important class A SBLs will inform the design of future DBOs, with the aim of improving clinical efficacy of BLI-ß-lactam combinations.


Subject(s)
Azabicyclo Compounds/pharmacology , Klebsiella pneumoniae/drug effects , Stenotrophomonas maltophilia/drug effects , beta-Lactam Resistance/genetics , beta-Lactamase Inhibitors/pharmacology , beta-Lactamases/chemistry , Azabicyclo Compounds/chemistry , Azabicyclo Compounds/metabolism , Aztreonam/chemistry , Aztreonam/metabolism , Aztreonam/pharmacology , Binding Sites , Ceftazidime/chemistry , Ceftazidime/metabolism , Ceftazidime/pharmacology , Chromosomes, Bacterial/chemistry , Chromosomes, Bacterial/enzymology , Clinical Trials, Phase III as Topic , Cloning, Molecular , Drug Combinations , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression , Genetic Vectors/chemistry , Genetic Vectors/metabolism , Humans , Imipenem/chemistry , Imipenem/metabolism , Imipenem/pharmacology , Isoenzymes/antagonists & inhibitors , Isoenzymes/chemistry , Isoenzymes/genetics , Isoenzymes/metabolism , Klebsiella pneumoniae/enzymology , Klebsiella pneumoniae/genetics , Microbial Sensitivity Tests , Models, Molecular , Plasmids/chemistry , Plasmids/metabolism , Protein Binding , Protein Interaction Domains and Motifs , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Stenotrophomonas maltophilia/enzymology , Stenotrophomonas maltophilia/genetics , beta-Lactamase Inhibitors/chemistry , beta-Lactamase Inhibitors/metabolism , beta-Lactamases/genetics , beta-Lactamases/metabolism
10.
Antonie Van Leeuwenhoek ; 112(5): 809-814, 2019 May.
Article in English | MEDLINE | ID: mdl-30467663

ABSTRACT

Inactivation of ahpC, encoding alkyl hydroperoxide reductase, rendered Stenotrophomonas maltophilia more resistant to H2O2; the phenotype was directly correlated with enhanced total catalase activity, resulting from an increased level of KatA catalase. Plasmid-borne expression of ahpC from pAhpCsm could complement all of the mutant phenotypes. Mutagenesis of the proposed AhpC peroxidactic and resolving cysteine residues to alanine (C47A and C166A) on the pAhpCsm plasmid diminished its ability to complement the ahpC mutant phenotypes, suggesting that the mutagenized ahpC was non-functional. As mutations commonly occur in bacteria living in hostile environment, our data suggest that point mutations in ahpC at codons required for the enzyme function (such as C47 and C166), the AhpC will be non-functional, leading to high resistance to the disinfectant H2O2.


Subject(s)
Bacterial Proteins/genetics , Disinfectants/pharmacology , Hydrogen Peroxide/pharmacology , Peroxiredoxins/genetics , Stenotrophomonas maltophilia/drug effects , Stenotrophomonas maltophilia/enzymology , Bacterial Proteins/metabolism , Drug Resistance, Bacterial , Gene Expression Regulation, Bacterial , Gene Silencing , Peroxiredoxins/metabolism , Stenotrophomonas maltophilia/genetics
11.
Int J Mol Sci ; 20(7)2019 Apr 10.
Article in English | MEDLINE | ID: mdl-30974814

ABSTRACT

Manganese-dependent superoxide dismutase (MnSOD, SodA) and iron-dependent SOD (FeSOD, SodB) are critical cytosolic enzymes for alleviating superoxide stress. Distinct from the singular sodA gene in most bacteria, Stenotrophomonas maltophilia harbors two sodA genes, sodA1 and sodA2. The roles of SodA1, SodA2, and SodB of S. maltophilia in alleviating superoxide stress were investigated. The expression of sod genes was determined by promoter-xylE transcriptional fusion assay and qRT-PCR. SodA2 and sodB expressions were proportional to the bacterial logarithmic growth, but unaffected by menadione (MD), iron, or manganese challenges. SodA1 was intrinsically unexpressed and inducibly expressed by MD. Complementary expression of sodA1 was observed when sodA2 was inactivated. The individual or combined sod deletion mutants were constructed using the gene replacement strategy. The functions of SODs were assessed by evaluating cell viabilities of different sod mutants in MD, low iron-stressed, and/or low manganese-stressed conditions. Inactivation of SodA1 or SodA2 alone did not affect bacterial viability; however, simultaneously inactivating sodA1 and sodA2 significantly compromised bacterial viability in both aerobic growth and stressed conditions. SodA1 can either rescue or support SodA2 when SodA2 is defective or insufficiently potent. The presence of two MnSODs gives S. maltophilia an advantage against superoxide stress.


Subject(s)
Bacterial Proteins/metabolism , Oxidative Stress , Stenotrophomonas maltophilia/enzymology , Superoxide Dismutase/metabolism , Superoxides/metabolism , Bacterial Proteins/genetics , Stenotrophomonas maltophilia/genetics , Superoxide Dismutase/genetics
12.
Biochim Biophys Acta Proteins Proteom ; 1866(3): 407-414, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29233759

ABSTRACT

Transglycosylation (TG) by family 18 chitinases is of special interest due to the many biological applications of long-chain chitooligosaccharides (CHOS). In the current study, the TG activity of chitinase A from Stenotrophomonas maltophilia (StmChiA) was improved through structure-guided mutations within and around the active site. Three independent mutants were created, targeting Trp residues from the -3 and -1 subsites and the central catalytic Asp from the DxDxE motif of StmChiA. The former was replaced with Ala and the latter with Asn. Changes in the hydrolytic and TG activities of the enzymes were assessed by monitoring the product profile of each mutant by high-performance liquid chromatography. All three mutants showed increased TG activity. Increased in the higher TG activity of mutant W306A was accompanied by increased hydrolysis. However, this mutant also accumulated substantial amounts of TG products during the first 15-30min of the reaction. In contrast, mutants D464N and W679A showed reduced hydrolysis, which was accompanied by the gradual accumulation of TG products up to 12h. Molecular docking studies with chitohexaose showed that the side chains of Trp residues mediate stacking interactions with sugar residues from the -3 and -1 subsites, indicating the importance of these residues in the enzymatic activity of StmChiA. Overall, mutants of the glycon-binding site (W306A and W679A) appear to produce long-chain CHOS more efficiently than the catalytic mutant D464N.


Subject(s)
Bacterial Proteins/metabolism , Catalytic Domain/genetics , Chitinases/metabolism , Mutation , Stenotrophomonas maltophilia/enzymology , Amino Acid Sequence , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Binding Sites/genetics , Chitin/analogs & derivatives , Chitin/chemistry , Chitin/metabolism , Chitinases/chemistry , Chitinases/genetics , Chitosan , Glycosylation , Hydrolysis , Kinetics , Molecular Docking Simulation , Oligosaccharides/chemistry , Oligosaccharides/metabolism , Sequence Homology, Amino Acid , Stenotrophomonas maltophilia/genetics , Substrate Specificity
13.
Mol Biol Rep ; 45(6): 1681-1689, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30168098

ABSTRACT

A novel feather-degrading bacterium named CA-1 was isolated from the gut of the spider Chilobrachys guangxiensis, which degrades native whole chicken feathers within 20 h. The CA-1 was confirmed to belong to Stenotrophomonas maltophilia based on morphologic and molecular analysis. Maximum feather degradation activity of the bacterium was observed at 37 °C in basal feather medium (NaCl 0.5 g/L, KH2PO4 0.3 g/L, K2HPO4 0.4 g/L, feather powder 10.0 g/L, pH 8.0), which was inhibited when glucose and ammonium nitrate were added in the medium. Furthermore, the purified enzymes under the optimal and suppressive conditions were analyzed respectively by SDS-PAGE and LC-MS/MS. Three enzymes, namely alkaline serine protease (29.1 kDa), ABC transporter permease (27.5 kDa), and alkaline phosphatase (40.8 kDa), were isolated and identified from the supernatant of the optimal culture and were considered to play principal roles. On the other hand, the potential synergic effects of the three proteins in S. maltophilia CA-1 feather degradation system were analyzed theoretically. CA-1 may product outer-membrane vesicles comprised of membranes and periplasmic proteins in the feather medium. The newly identified CA-1 and its synergic enzymes provide a new insight into further understanding the molecular mechanism of feather degradation by microbes. They also have potential application in cost-effectively degrading feathers into feeds and fertilizers through careful optimization and engineering of the three newly identified enzymes.


Subject(s)
Feathers/enzymology , Stenotrophomonas maltophilia/enzymology , Stenotrophomonas maltophilia/metabolism , ATP-Binding Cassette Transporters/isolation & purification , ATP-Binding Cassette Transporters/metabolism , Alkaline Phosphatase/isolation & purification , Alkaline Phosphatase/metabolism , Animals , Bacteria/metabolism , Culture Media , Feathers/microbiology , Keratins/metabolism , Membrane Transport Proteins/isolation & purification , Membrane Transport Proteins/metabolism , Phylogeny , Proteolysis , Serine Endopeptidases/isolation & purification , Serine Endopeptidases/metabolism , Spiders/microbiology , Stenotrophomonas maltophilia/isolation & purification , Substrate Specificity
14.
Mem Inst Oswaldo Cruz ; 113(6): e170558, 2018 May 14.
Article in English | MEDLINE | ID: mdl-29768625

ABSTRACT

This study reports the presence of the blaNDM-1 gene in an isolate of Stenotrophomonas maltophilia obtained from a Brazilian soil, inside an IncA/C plasmid with ~ 45 Kb. To the best of our knowledge, this is the second report in the world and the first in Brazil of NDM-producing bacterium isolated from soil.


Subject(s)
Soil Microbiology , Stenotrophomonas maltophilia/enzymology , beta-Lactamases/genetics , Anti-Bacterial Agents/pharmacology , Disk Diffusion Antimicrobial Tests , Stenotrophomonas maltophilia/drug effects , Stenotrophomonas maltophilia/isolation & purification
15.
Bioprocess Biosyst Eng ; 41(3): 381-393, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29204731

ABSTRACT

In the present study, keratinase from Stenotrophomonas maltophilia R13 was used for the first time as a reducing agent for the eco-friendly synthesis of AgNPs. The keratinase produced by strain R13 was responsible for the reduction of silver ions and the subsequent formation of AgNPs. Maximum AgNP synthesis was achieved using 2 mM AgNO3 at pH 9 and 40 °C. Electron microscopy and dynamic light scattering analysis showed AgNPs were spherical and of average diameter ~ 8.4 nm. X-ray diffraction revealed that AgNPs were crystalline. FTIR indicated AgNPs were stabilized by proteins present in the crude enzyme solution of strain R13. AgNPs exhibited a broad antimicrobial spectrum against several pathogenic microorganisms, and the antimicrobial mechanism appeared to involve structural deformation of cells resulting in membrane leakage and subsequent lysis. AgNPs also displayed 1,1-diphenyl-2-picrylhydrazyl (IC50 = 0.0112 mg/ml), 2,2'-azinobis-3-ethylbenzothiazoline-6-sulfonate radical scavenging (IC50 = 0.0243 mg/ml), and anti-collagenase (IC50 = 23.5 mg/ml) activities.


Subject(s)
Anti-Infective Agents/chemistry , Bacterial Proteins/chemistry , Metal Nanoparticles/chemistry , Peptide Hydrolases/chemistry , Silver/chemistry , Stenotrophomonas maltophilia/enzymology , Anti-Infective Agents/pharmacology , Silver/pharmacology , Silver Nitrate/chemistry , Structure-Activity Relationship
16.
Molecules ; 23(2)2018 Feb 13.
Article in English | MEDLINE | ID: mdl-29438314

ABSTRACT

An Gram negative strain of S. maltophilia, indigenous to environments contaminated by Cr(VI) and identified by biochemical methods and 16S rRNA gene analysis, reduced chromate by 100%, 98-99% and 92% at concentrations in the 10-70, 80-300, and 500 mg/L range, respectively at pH 7 and temperature 37 °C. Increasing concentrations of Cr(VI) in the medium lowered the growth rate but could not be directly correlated with the amount of Cr(VI) reduced. The strain also exhibited multiple resistance to antibiotics and tolerance and resistance to various heavy metals (Ni, Zn and Cu), with the exception of Hg. Hexavalent chromium reduction was mainly associated with the soluble fraction of the cell evaluated with crude cell-free extracts. A protein of molecular weight around 25 kDa was detected on SDS-PAGE gel depending on the concentration of hexavalent chromium in the medium (0, 100 and 500 mg/L). In silico analysis in this contribution, revealed the presence of the chromate reductase gene ChrR in S. maltophilia, evidenced through a fragment of around 468 bp obtained experimentally. High Cr(VI) concentration resistance and high Cr(VI) reducing ability of the strain make it a suitable candidate for bioremediation.


Subject(s)
Bacterial Proteins/metabolism , Chromium/metabolism , Drug Resistance, Multiple, Bacterial/genetics , Oxidoreductases/metabolism , RNA, Ribosomal, 16S/genetics , Stenotrophomonas maltophilia/drug effects , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Bacterial Proteins/isolation & purification , Biodegradation, Environmental , Chromium/pharmacology , Copper/metabolism , Copper/pharmacology , Drug Tolerance , Gene Expression , Hydrogen-Ion Concentration , Microbial Sensitivity Tests , Molecular Weight , Nickel/metabolism , Nickel/pharmacology , Oxidation-Reduction , Oxidoreductases/genetics , Oxidoreductases/isolation & purification , Phylogeny , Stenotrophomonas maltophilia/classification , Stenotrophomonas maltophilia/enzymology , Stenotrophomonas maltophilia/genetics , Temperature , Zinc/metabolism , Zinc/pharmacology
17.
Biochemistry ; 56(2): 348-351, 2017 Jan 17.
Article in English | MEDLINE | ID: mdl-28029240

ABSTRACT

The first ß-lactone synthetase enzyme is reported, creating an unexpected link between the biosynthesis of olefinic hydrocarbons and highly functionalized natural products. The enzyme OleC, involved in the microbial biosynthesis of long-chain olefinic hydrocarbons, reacts with syn- and anti-ß-hydroxy acid substrates to yield cis- and trans-ß-lactones, respectively. Protein sequence comparisons reveal that enzymes homologous to OleC are encoded in natural product gene clusters that generate ß-lactone rings, suggesting a common mechanism of biosynthesis.


Subject(s)
Bacterial Proteins/genetics , Coenzyme A Ligases/genetics , Gene Expression Regulation, Bacterial , Lactones/metabolism , Micrococcus luteus/genetics , Stenotrophomonas maltophilia/genetics , Streptomyces/genetics , Alkenes/metabolism , Amino Acid Sequence , Bacterial Proteins/metabolism , Biological Products/metabolism , Coenzyme A Ligases/metabolism , Hydroxy Acids , Micrococcus luteus/enzymology , Multigene Family , Operon , Sequence Homology, Amino Acid , Stenotrophomonas maltophilia/enzymology , Streptomyces/enzymology
18.
Infect Immun ; 85(12)2017 12.
Article in English | MEDLINE | ID: mdl-28893914

ABSTRACT

Stenotrophomonas maltophilia is an emerging, opportunistic nosocomial pathogen that can cause severe disease in immunocompromised individuals. We recently identified the StmPr1 and StmPr2 serine proteases to be the substrates of the Xps type II secretion system in S. maltophilia strain K279a. Here, we report that a third serine protease, StmPr3, is also secreted in an Xps-dependent manner. By constructing a panel of protease mutants in strain K279a, we were able to determine that StmPr3 contributes to the previously described Xps-mediated rounding and detachment of cells of the A549 human lung epithelial cell line as well as the Xps-mediated degradation of fibronectin, fibrinogen, and the cytokine interleukin-8 (IL-8). We also determined that StmPr1, StmPr2, and StmPr3 account for all Xps-mediated effects toward A549 cells and that StmPr1 contributes the most to Xps-mediated activities. Thus, we purified StmPr1 from the S. maltophilia strain K279a culture supernatant and evaluated the protease's activity toward A549 cells. Our analyses revealed that purified StmPr1 behaves more similarly to subtilisin than to trypsin. We also determined that purified StmPr1 likely induces cell rounding and detachment of A549 cells by targeting cell integrin-extracellular matrix connections (matrilysis) as well as adherence and tight junction proteins for degradation. In this study, we also identified anoikis as the mechanism by which StmPr1 induces the death of A549 cells and found that StmPr1 induces A549 IL-8 secretion via activation of protease-activated receptor 2. Altogether, these results suggest that the degradative and cytotoxic activities exhibited by StmPr1 may contribute to S. maltophilia pathogenesis in the lung by inducing tissue damage and inflammation.


Subject(s)
Anoikis , Epithelial Cells/microbiology , Epithelial Cells/physiology , Receptor, PAR-2/metabolism , Serine Proteases/metabolism , Stenotrophomonas maltophilia/pathogenicity , Virulence Factors/metabolism , A549 Cells , Gene Deletion , Humans , Serine Proteases/genetics , Stenotrophomonas maltophilia/enzymology , Stenotrophomonas maltophilia/genetics
19.
Appl Environ Microbiol ; 83(9)2017 05 01.
Article in English | MEDLINE | ID: mdl-28235876

ABSTRACT

Oleate hydratases (OhyAs) catalyze the conversion of unsaturated fatty acids to 10-hydroxy fatty acids, which are used as precursors of important industrial compounds, including lactones and ω-hydroxycarboxylic and α,ω-dicarboxylic acids. The genes encoding OhyA and a putative fatty acid hydratase in Stenotrophomonas maltophilia were identified by genomic analysis. The putative fatty acid hydratase was purified and identified as an oleate hydratase (OhyA2) based on its substrate specificity. The activity of OhyA2 as a holoenzyme was not affected by adding cofactors, whereas the activity of the original oleate hydratase (OhyA1) showed an increase. Thus, all characterized OhyAs were categorized as either OhyA1 or OhyA2 based on the activities of holoenzymes upon adding cofactors, which were determined by the type of the fourth conserved amino acid of flavin adenine dinucleotide (FAD)-binding motif. The hydration activities of S. maltophilia OhyA2 toward unsaturated fatty acids, including oleic acid, palmitoleic acid, linoleic acid, α-linolenic acid, and γ-linolenic acid, were greater than those of OhyA1. Moreover, the specific activity of S. maltophilia OhyA2 toward unsaturated fatty acids, with the exception of γ-linolenic acid, was the highest among all reported OhyAs.IMPORTANCE All characterized OhyAs were categorized as OhyA1s or OhyA2s based on the different properties of the reported and newly identified holo-OhyAs in S. maltophilia upon the addition of cofactors. OhyA2s showed higher activities toward polyunsaturated fatty acids (PUFAs), including linoleic acid, α-linolenic acid, and γ-linolenic acid, than those of OhyA1s. This suggests that OhyA2s can be used more effectively to convert plant oils to 10-hydroxy fatty acids because plant oils contain not only oleic acid but also PUFAs. The hydration activity of the newly identified OhyA2 from S. maltophilia toward oleic acid was the highest among the activity levels reported so far. Therefore, this enzyme is an efficient biocatalyst for the conversion of plant oils to 10-hydroxy fatty acids, which can be further converted to important industrial materials.


Subject(s)
Fatty Acids, Unsaturated/metabolism , Hydro-Lyases/metabolism , Oleic Acid/metabolism , Stenotrophomonas maltophilia/enzymology , Coenzymes/metabolism , Hydro-Lyases/isolation & purification , Kinetics , Substrate Specificity
20.
Antimicrob Agents Chemother ; 60(4): 2516-8, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26787686

ABSTRACT

The treatment ofStenotrophomonas maltophiliainfection with ß-lactam antibiotics leads to increased release of outer membrane vesicles (OMVs), which are packed with two chromosomally encoded ß-lactamases. Here, we show that these ß-lactamase-packed OMVs are capable of establishing extracellular ß-lactam degradation. We also show that they dramatically increase the apparent MICs of imipenem and ticarcillin for the cohabituating speciesPseudomonas aeruginosaandBurkholderia cenocepacia.


Subject(s)
Burkholderia cenocepacia/genetics , Extracellular Vesicles/enzymology , Pseudomonas aeruginosa/genetics , Stenotrophomonas maltophilia/genetics , beta-Lactam Resistance/genetics , beta-Lactamases/metabolism , Anti-Bacterial Agents/pharmacology , Burkholderia cenocepacia/drug effects , Burkholderia cenocepacia/enzymology , Cell Membrane/chemistry , Conjugation, Genetic , Extracellular Vesicles/chemistry , Gene Expression , Gene Transfer, Horizontal , Hydrolysis , Imipenem/pharmacology , Microbial Sensitivity Tests , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/enzymology , Stenotrophomonas maltophilia/drug effects , Stenotrophomonas maltophilia/enzymology , Ticarcillin/pharmacology , beta-Lactamases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL